Shanghai No.1 Pharmacy Co., Ltd.

Sembol: 600833.SS

SHH

10.6

CNY

Bugünkü piyasa fiyatı

27.0851
F/K Oranı
3.3571
PEG Oranı
2.36B
MRK Kapağı
0.02%
DIV Verimi

Shanghai No.1 Pharmacy Co., Ltd. (600833-SS) Finansal Tablolar

Download

Yıllık Üç Aylık

Doğrusal Günlük

Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz Shanghai No.1 Pharmacy Co., Ltd. (600833.SS). Şirketin geliri NaN M ortalamasını gösterir ki bu da NaN % gowth'dur. Tüm dönem için ortalama brüt kar NaN M olup NaN % dir. Ortalama brüt kar oranı NaN %dır. Şirketin geçen yılki performansı için net gelir artışı NaN % olup NaN % %'ne eşittir. tüm şirket geçmişi için ortalama.,

Yıllık Üç Aylık

10Y 20Y 30Y 40Y

Bilanço

Shanghai No.1 Pharmacy Co., Ltd.'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin NaN olduğu görülür. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde NaN olarak değerlenir. Bu açıdan yıldan yıla değişim NaN%'dir.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	496.5	725.2	262.3	509.4	473.7	388	323.8	227.8	199.9	163.3	155.4	163.7	170.3	160.6	145.6	106.1	113.6	92.3	28.3	36.2	52.2	45.1	54.9	1	0.8	4.4	139.8	165.9	137.4	0
balance-sheet.row.short-term-investments	96.4	220.3	-9.3	-8.9	0	194	0	0	0	335.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	27.8	0
balance-sheet.row.net-receivables	278.4	293.2	183.8	153.7	149.6	126	155	131	132.3	136.5	138.4	118.9	134.6	111.9	83.5	73.9	75	63.1	33.3	44.2	53.8	39.7	67.4	2.7	11.3	240.2	302.8	553.7	356.3	0
balance-sheet.row.inventory	332.2	334.8	214.5	215.6	220.7	216.9	205.9	296.4	261.8	273.5	235.3	235.2	216.5	186.4	183.5	169.6	149.1	134.6	120.4	131.7	151.1	152.8	162.2	366.9	580.3	615.7	617.4	534.2	588.5	0
balance-sheet.row.other-current-assets	10.1	44	2.1	0.6	5.1	6.8	1.5	14.7	10.3	12.7	-2.3	-2.5	-4.1	-2.3	-2.6	-2.3	-2.1	-2.3	-7.6	-6.2	-10.8	0	-14.6	52.6	81.1	-97.8	-118.6	-129.7	0.1	548
balance-sheet.row.total-current-assets	1117.2	1397.1	662.7	879.4	849.2	737.7	686.2	669.8	604.3	586	526.8	515.4	517.3	456.6	410.1	347.2	335.6	287.7	174.4	205.8	246.4	237.7	269.9	423.2	673.6	762.5	941.4	1124.1	1082.3	548
balance-sheet.row.property-plant-equipment-net	215.4	181.1	168	72.5	75.4	79.8	86.2	83.8	88.2	90.5	97.4	100	56.1	61.8	56.3	61.3	69.8	75.8	147.6	188.5	202.7	185	180	21.3	23.5	24.6	5.3	5.8	6.1	3.8
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	1.2	0	1.2	1.2	1.2	1.2	1.2	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	41.7	43.8	46.3	48.2	50.8	53.7	57.2	59.8	59.4	62	67.5	70.1	73	75.4	73.8	76.2	77.5	81.3	0.8	3	3.3	3.2	3.1	0	0	0	0	4.4	3.2	0
balance-sheet.row.goodwill-and-intangible-assets	41.7	43.8	46.3	48.2	50.8	53.7	57.2	59.8	59.4	62	67.5	70.1	73	75.4	73.8	76.3	78.7	81.3	2	4.2	4.5	4.4	4.3	0	0	0	0	4.4	3.2	0
balance-sheet.row.long-term-investments	446.2	32.2	193.4	189.1	226.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	73.3	0
balance-sheet.row.tax-assets	26.4	36	12.1	7.2	8.3	5.8	6.2	5.9	5.8	5.8	5.7	6.1	7.1	6.9	6.6	6.3	6.1	0	0	0	0	0	0	0	0	0	0	0	27.8	0
balance-sheet.row.other-non-current-assets	16.3	348.9	252	200	6.2	202.5	300.2	366	472.4	336.7	218.6	200.6	140.6	187.6	174.8	98	206.3	36.4	19.6	30.5	31.5	51.4	28.6	34.6	48.7	199.8	229	250.2	24.4	172.1
balance-sheet.row.total-non-current-assets	745.9	642	671.8	516.9	367.4	341.7	449.7	515.4	625.8	495	389.3	376.9	276.9	331.6	311.5	241.9	361	193.5	169.3	223.2	238.7	240.7	212.9	56	72.2	224.4	234.3	260.4	134.9	175.9
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	1863.2	2039.1	1334.5	1396.3	1216.6	1079.5	1136	1185.3	1230.1	1081	916.2	892.3	794.2	788.2	721.6	589.1	696.6	481.1	343.7	429	485.1	478.4	482.8	479.1	745.7	986.8	1175.6	1384.6	1217.2	723.8
balance-sheet.row.account-payables	338.3	363.7	314.8	292	328.9	265.6	261.8	288.1	251	267.7	251.6	253.8	241.5	208.4	182.2	160.7	150.6	146.1	73.7	88.4	99.6	96	107.2	48.7	60	12.8	12	87.7	76.6	0
balance-sheet.row.short-term-debt	219.7	369.8	39.4	180.6	0.5	22.5	22.5	22.5	22.5	22.5	22.5	22.5	22.5	22.5	22.5	22.5	22.5	32.5	22.5	80.6	102.3	107.6	98.2	577.2	749.1	749	674.5	744.3	495.9	0
balance-sheet.row.tax-payables	10.3	39.3	9.4	8.2	9.3	10.9	6.3	4.8	9.7	6.1	-1	1.7	-2.4	-4.4	-6	-4.9	-2	-1.3	-7.5	9.2	-6.4	-3.5	-2.6	-12.6	-15.2	-14.7	14.1	10	-3.5	0
balance-sheet.row.long-term-debt-total	107.2	88.3	63.1	88.8	1.1	0	0	0	0	0	-14.7	0	0	0	0	0	0	0	0	0	0	0	3.4	37.9	38.9	34.9	59.3	40.9	88.6	0
Deferred Revenue Non Current	12.4	11.3	11.7	12.4	12.4	13.2	13.9	13.6	14	14.3	14.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	113.1	167.3	1.7	2.9	1.7	56.8	3.7	0.8	4.3	4.1	3.7	8.8	9.6	6.6	11.5	6.8	3.8	4.1	5.1	4.4	8.8	8.4	19.2	24.8	23.2	39.6	57.9	60.8	104.7	427.6
balance-sheet.row.total-non-current-liabilities	165.5	154	112.5	49.6	62	54.1	80	96.3	123.3	89.6	60.4	56.3	26.2	38	34.9	14.6	45.1	0	0	0	14.8	15.3	19.2	34.1	35.9	32	61	60.7	113.6	109.4
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	107.2	88.3	63.1	88.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	842.3	1080.4	556.5	646.9	484.2	409.9	421.9	449.3	447	430	380	392.4	364.8	352.3	319.3	275	303	235.4	111	226.4	295.6	302.1	317.2	879.4	1024	886.9	830.3	1079.3	929.6	537.1
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	223.1	223.1	223.1	223.1	223.1	223.1	223.1	223.1	223.1	223.1	223.1	223.1	223.1	159.3	159.3	159.3	159.3	159.3	159.3	159.3	159.3	159.3	159.3	159.3	159.3	159.3	122.6	92	83.6	69.7
balance-sheet.row.retained-earnings	458.5	437.4	309.5	290.7	243.4	208.5	176.5	152.6	124.3	97.8	75.6	56.1	35.6	66.9	52.5	27.7	18	-5.1	-17.8	-677.6	-690.3	-702.8	-714.8	-735.3	-606.4	-235.6	25.3	-1.6	-1	29.9
balance-sheet.row.accumulated-other-comprehensive-income-loss	280.7	252	199.1	189.3	219.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	39.2	39.2	39.2	39.3	39.2	231	307.4	353.3	428.7	323.1	230.5	213.7	163.7	202.7	190.4	126.5	215.4	90.7	91.1	720.6	720.2	719.8	720.9	175.2	168.3	175.7	192.6	110.4	99.6	87.1
balance-sheet.row.total-stockholders-equity	1001.4	951.7	770.9	742.3	725.3	662.6	707.1	729	776.1	644	529.1	492.8	422.4	428.9	402.3	313.5	392.8	244.9	232.7	202.4	189.2	176.3	165.5	-400.8	-278.8	99.5	340.5	200.8	182.3	186.7
balance-sheet.row.total-liabilities-and-stockholders-equity	1863.2	2039.1	1334.5	1396.3	1216.6	1079.5	1136	1185.3	1230.1	1081	916.2	892.3	794.2	788.2	721.6	589.1	696.6	481.1	343.7	429	485.1	478.4	482.8	479.1	745.7	986.8	1175.6	1384.6	1217.2	723.8
balance-sheet.row.minority-interest	7	7	7	7	7	7	7	7	7	7	7	7	7	7	0	0.6	0.8	0.9	0	0.3	0.3	0	0	0.5	0.5	0.5	4.8	104.5	105.3	0
balance-sheet.row.total-equity	1008.5	958.7	777.9	749.3	732.3	669.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	542.7	252.5	184.1	180.1	226.7	194	298.5	364.8	471.2	335.4	217.4	200	140.6	187.6	174.8	98	206.2	36.3	19.5	29.4	31.5	34.6	19.9	145.3	162.6	166.6	19.3	1.1	101.1	0
balance-sheet.row.total-debt	326.9	458.2	102.5	180.6	0.5	22.5	22.5	22.5	22.5	22.5	22.5	22.5	22.5	22.5	22.5	22.5	22.5	32.5	22.5	80.6	102.3	107.6	98.2	615.1	788	783.9	733.8	785.2	584.5	0
balance-sheet.row.net-debt	-73.1	-46.8	-159.8	-328.8	-473.2	-365.5	-301.3	-205.3	-177.4	-140.8	-132.9	-141.2	-147.8	-138.1	-123.1	-83.6	-91.1	-59.8	-5.8	44.4	50.2	62.5	43.3	614.1	787.2	779.5	594	620.4	474.9	0

Nakit Akış Tablosu

Shanghai No.1 Pharmacy Co., Ltd.'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek NaN şeklinde bir değişim sergilemiştir. Şirket kısa süre önce NaN ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla NaN oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden NaN tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre NaN değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan NaN, NaN ve NaN 'i kaydetti. Şirketin finansman faaliyetleri NaN net nakit kullanımına yol açmış ve bir önceki yıla göre NaN farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için NaN ayırmıştır. Aynı zamanda, NaN olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	89.3	143.6	49.4	68.5	53.1	47.2	43.5	46	41.2	37	34.3	36.4	36.7	30.3	40	20	20.1	13.1	14.2	13.1	12.9	12.7	24.2	-136.5	-185.9	-143.2
cash-flows.row.depreciation-and-amortization	59.8	48.3	45.2	8.4	9.3	9.5	9	9	9.2	11.3	9.4	10.8	9.3	9.1	10.5	12.7	15.6	13.7	15.1	14.5	8.3	8.8	4.5	1.3	1.7	10.4
cash-flows.row.deferred-income-tax	9.9	-23.9	-4.1	1.1	-2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	-156.8	23.9	4.1	-1.1	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-37.2	-117.9	-65.6	-4	36.4	21.1	69.3	-12.2	1.3	-31	-35.3	11.1	-19	1.2	-0.8	-9.8	8	58.9	-2	-25.7	-1.7	1.4	32.3	61.2	25.3	-89
cash-flows.row.account-receivables	-3.7	-124.1	-43.2	-1.1	-22.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	11	-124	-1	0.8	-7.2	-10.4	89.5	-34.5	11.7	-38.2	-0.1	-19.2	-30.1	8.1	-13.9	-20.5	-14.6	-14.2	11.3	19.5	1.7	9.3	-34.9	65.1	-12.5	-67.9
cash-flows.row.account-payables	-44.5	153.9	-17.2	-4.8	68.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-23.9	-4.1	1.1	-2.5	31.5	-20.1	22.4	-10.4	7.2	-35.2	30.3	11	-7	13.1	10.7	22.5	73.1	-13.3	-45.1	-3.4	-8	67.1	-3.8	37.8	-21
cash-flows.row.other-non-cash-items	117.4	58.4	7.6	11.3	5.7	-35	-1.8	-6.5	-2.8	1.9	-1.8	-2.1	-2.3	-0.7	-22.6	-2.2	-2.3	-2.7	-13	0.9	6.9	2.2	-4.5	76	156.3	89.1
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-13.9	-11.4	-12.6	-12.2	-10	-9.1	-13.6	-2.6	-5.7	-4	-7.3	-54.4	-9.3	-10.3	-5.1	-4.1	-8.2	-15.4	-3.4	-8.7	-18.8	-23.3	-5	-0.1	-0.2	-0.2
cash-flows.row.acquisitions-net	62.1	0.1	2.2	12.3	10	-0.2	0	0	0	0	0	0	0	0.1	5.2	4.1	9.5	0	0	19.3	20.8	23.3	0.1	0	0	0.2
cash-flows.row.purchases-of-investments	-442	-401	-51	-200	-0.3	47.6	0	0	0	0	0	0	0	10.4	-1.6	-13.5	-2.4	-37	0	-0.3	-0.6	-16.4	-0.5	0	0	-0.6
cash-flows.row.sales-maturities-of-investments	537.2	284.5	2.2	1.9	6.1	5.5	4.9	7.2	4.3	3.6	3.4	2.8	2.4	2.1	27.5	2.8	3	3.5	16.7	6	7.4	3.5	59.4	0.5	0.2	0.5
cash-flows.row.other-investing-activites	0	0	0	-12.2	-10	-9.1	0.2	0.4	0.3	0.3	0.3	0.2	0	-10.3	-5.1	-4.1	-8.2	29.8	-17.3	-8.7	-18.8	-23.3	24.8	0	0.2	-0.2
cash-flows.row.net-cash-used-for-investing-activites	143.4	-127.8	-59.2	-210.2	-4.1	34.8	-8.5	5	-1.1	-0.2	-3.7	-51.4	-6.9	-8.1	21	-14.7	-6.4	-19	-4	7.5	-10.1	-36.2	78.9	0.4	0.2	-0.2
cash-flows.row.debt-repayment	-224.9	-550	-180	-180	0	0	0	0	0	0	0	0	0	0	0	-5	-15	-5	-71.6	-123.5	-171.4	-4.4	-131.2	0	-131.7	-887.4
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-43.5	-27.4	-22.4	-18.3	-14.7	-13.4	-15.6	-13.4	-11.1	-11.2	-11.2	-11.5	-8	-15.3	-8.5	-8.5	-3.6	-0.1	-2.9	-4.7	-4.1	-3.6	-3.5	-2.2	-2	-49.5
cash-flows.row.other-financing-activites	-62.6	826.6	-33.6	360	-0.2	0	0	0	0	-0.3	0	2	0	-3.6	2	-1.4	4.9	5.1	56.4	101.7	166.4	9.4	53.2	0	132.5	933.6
cash-flows.row.net-cash-used-provided-by-financing-activities	-331.1	249.1	-236.1	161.7	-14.7	-13.4	-15.6	-13.4	-11.1	-11.5	-11.2	-9.5	-8	-18.8	-6.4	-14.9	-13.7	0	-18	-26.5	-9.1	1.4	-81.4	-2.2	-1.2	-3.2
cash-flows.row.effect-of-forex-changes-on-cash	0.5	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-104.9	254.3	-258.8	35.7	85.7	64.2	96	28	36.5	7.6	-8.3	-4.6	9.7	13	41.6	-8.9	21.3	64	-7.8	-16	7.1	-9.8	53.9	0.2	-3.5	-136.1
cash-flows.row.cash-at-end-of-period	400	504.6	250.4	509.1	473.4	387.7	323.5	227.5	199.6	163	155.4	163.7	168.4	158.6	145.6	104	113.6	92.3	28.3	36.2	52.2	45.1	54.9	1	0.8	4.4
cash-flows.row.cash-at-beginning-of-period	504.9	250.4	509.1	473.4	387.7	323.5	227.5	199.6	163	155.4	163.7	168.4	158.6	145.6	104	112.9	92.3	28.3	36.2	52.2	45.1	54.9	0.9	0.7	4.4	140.4
cash-flows.row.operating-cash-flow	82.2	132.3	36.6	84.2	104.6	42.8	120.1	36.4	48.8	19.2	6.5	56.2	24.7	39.9	27.1	20.7	41.4	83	14.2	2.9	26.3	25.1	56.5	2	-2.6	-132.7
cash-flows.row.capital-expenditure	-13.9	-11.4	-12.6	-12.2	-10	-9.1	-13.6	-2.6	-5.7	-4	-7.3	-54.4	-9.3	-10.3	-5.1	-4.1	-8.2	-15.4	-3.4	-8.7	-18.8	-23.3	-5	-0.1	-0.2	-0.2
cash-flows.row.free-cash-flow	68.4	120.9	23.9	72	94.6	33.7	106.5	33.8	43.1	15.2	-0.8	1.8	15.3	29.6	22	16.7	33.1	67.6	10.8	-5.8	7.5	1.8	51.5	1.9	-2.8	-132.9

Gelir Tablosu Satırı

Shanghai No.1 Pharmacy Co., Ltd.'nın geliri bir önceki döneme göre NaN% oranında bir değişim gösterdi. Şirketin 600833.SS brüt kârı NaN olarak raporlanmıştır. Şirketin işletme giderleri NaN olup, geçen yıla göre NaN% değişim göstermiştir. Amortisman ve itfa giderleri NaN, yani NaN% son hesap dönemine göre değişimdir. İşletme giderleri NaN olarak raporlanmıştır ve yıldan yıla NaN% değişim göstermektedir. Satış ve pazarlama giderleri NaN, bir önceki yıla göre NaN% değişimdir. Son rakamlara göre FAVÖK NaN olup, yıldan yıla NaN% büyümeyi temsil etmektedir. Faaliyet geliri NaN olup, bir önceki yıla göre NaN% değişim göstermektedir. Net gelirdeki değişim NaN%'dir. Geçen yılın net geliri NaN idi.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992
income-statement-row.row.total-revenue	1811.2	2655.9	1398.3	1586.9	1243.2	1176.7	1556.1	1519	1491	1414.7	1348.4	1357.7	1268.3	1147.5	1037	964.5	910	602.9	601.6	545.5	507	476.5	263.2	4.2	-9.2	-51.9	290.2	276.3	207.4	122.5	56.3	36.5
income-statement-row.row.cost-of-revenue	1521.1	2110.8	1150.3	1304.7	994.4	948.7	1309.4	1280.8	1262.1	1190.1	1128.4	1123.2	1050.8	946.7	852.4	790.9	732.5	496.9	482.3	426.3	389.9	367	206.3	11.3	0.7	-25.3	193.8	180.3	168.8	0	47.1	32.5
income-statement-row.row.gross-profit	290	545.1	248	282.2	248.8	227.9	246.8	238.3	228.9	224.7	220	234.4	217.5	200.8	184.6	173.7	177.5	106	119.3	119.2	117	109.6	56.9	-7.1	-10	-26.5	96.4	96	38.5	122.5	9.2	4
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-1	74.2	54.8	60.9	75	-0.3	0.7	2.1	5.3	4.3	3.4	1.8	2.4	1	1.4	-0.2	0.2	13.7	13.6	11.8	10.1	8.3	7.4	-22.3	-11.7	-12.6	13.9	-13	6.1	1.3	2.5	0.9
income-statement-row.row.operating-expenses	281.4	314.4	233.1	223.7	208.6	215.6	198.8	195.7	188.8	182.9	181.4	183.4	167.9	159	153.2	148.9	149.6	102.8	118.8	115.6	111	100.5	44.2	16.9	29	16.6	31.6	31.4	23.6	1.3	2.5	0.9
income-statement-row.row.cost-and-expenses	1802.5	2425.2	1383.3	1528.4	1203	1164.4	1508.2	1476.5	1450.9	1372.9	1309.8	1306.6	1218.7	1105.7	1005.6	939.7	882.1	599.7	601.1	541.9	501	467.5	250.5	28.2	29.8	-8.7	225.4	211.6	192.4	1.3	2.5	0.9
income-statement-row.row.interest-income	13.6	13.8	22.3	18.3	9.6	5.5	6	6.6	5.8	5.3	1	1	1.5	0.4	0.3	1	0	0.4	0.3	0.6	0.6	0.6	0.5	0	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	7.6	14.1	3.2	1.7	0.2	5.4	5.9	6.5	5.7	5.1	0.9	0	0	0	0	0.5	1.1	0.1	2.9	3.4	4	4.4	2.4	35.3	109	83	53.5	37	11.5	0	0	0
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	109.9	-0.1	-3.9	-7.1	-4.1	46.7	9.4	15.7	14.5	8	6.3	2.1	2.4	-0.5	22.2	1.2	2	1.4	0.9	-1.6	-1.2	-0.8	10.5	-112.7	-154	-100.1	-34.1	-33.6	13.4	-96.1	9.2	0
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-1	74.2	54.8	60.9	75	-0.3	0.7	2.1	5.3	4.3	3.4	1.8	2.4	1	1.4	-0.2	0.2	13.7	13.6	11.8	10.1	8.3	7.4	-22.3	-11.7	-12.6	13.9	-13	6.1	1.3	2.5	0.9
income-statement-row.row.total-operating-expenses	109.9	-0.1	-3.9	-7.1	-4.1	46.7	9.4	15.7	14.5	8	6.3	2.1	2.4	-0.5	22.2	1.2	2	1.4	0.9	-1.6	-1.2	-0.8	10.5	-112.7	-154	-100.1	-34.1	-33.6	13.4	-96.1	9.2	0
income-statement-row.row.interest-expense	7.6	14.1	3.2	1.7	0.2	5.4	5.9	6.5	5.7	5.1	0.9	0	0	0	0	0.5	1.1	0.1	2.9	3.4	4	4.4	2.4	35.3	109	83	53.5	37	11.5	0	0	0
income-statement-row.row.depreciation-and-amortization	59.8	105.9	45.2	8.4	9.3	9.5	9	9	9.2	11.3	9.4	10.8	9.3	9.1	10.5	12.7	15.6	13.7	15.1	14.5	8.3	8.8	4.5	1.3	1.7	10.4	40	21	-15.2	97.5	-9.2	-4
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	8.6	190.6	69.1	97.8	72.7	59.3	56.7	56.3	49.9	45.7	41.6	51.7	49.8	40.4	52.4	26.3	29.8	18.7	15.2	14.3	13.2	14.4	25.9	-114.1	-181.2	-130.6	24.8	43.6	30.2	25.1	6.6	3.1
income-statement-row.row.income-before-tax	118.5	190.5	65.2	90.7	68.6	59	57.4	58.2	54.6	49.8	44.9	53.1	52	41.3	53.6	26	30	18.5	15.1	14.1	14.1	15.5	28.3	-136.5	-193	-143.2	34.7	30.9	32.4	26.4	15.8	3.1
income-statement-row.row.income-tax-expense	28.2	47	15.8	22.1	15.5	11.8	13.9	12.2	13.4	12.8	10.6	16.7	15.3	11	13.6	6	9.8	5.5	0.9	1	1.2	2.8	4.1	-28.8	3.6	-3	5.2	3.6	4	1.6	2.3	0.5
income-statement-row.row.net-income	89.3	143.6	49.4	68.5	53.1	47.2	43.5	46	41.2	37	34.3	36.4	36.7	30.3	40	20	20.1	13	14.2	13.1	12.9	12.7	24.2	-136.5	-185.9	-140.3	31.1	20.4	18.8	24.8	13.5	2.6